Document Detail


ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor.
MedLine Citation:
PMID:  19404519     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Inhibitor development is a rare but serious event in hemophilia B patients. Management is hampered by the frequent occurrence of allergic reactions to factor IX, low success rates of current inhibitor elimination protocols and the risk of development of nephrotic syndrome. Single cases of immune tolerance induction (ITI) including immunosuppressive agents like mycophenolat mofetil (MMF) or rituximab have been reported. We present a case of successful inhibitor elimination with a combined immune-modulating therapy and high-dose factor IX (FIX). This boy had developed a FIX inhibitor at the age of 5 years and had a history of allergic reactions to FIX and to FEIBAO. Under on-demand treatment with recombinant activated FVII the inhibitor became undetectable but the boy suffered from multiple joint and muscle bleeds. At the age of 11.5 years ITI was attempted with a combination of rituximab, MMF, dexamethasone, intravenous immunoglobulins and high-dose FIX. The inhibitor did not reappear and FIX half-life normalized. No allergic reaction, no signs of nephrotic syndrome and no serious infections were observed.
Authors:
Karin Beutel; H Hauch; J Rischewski; U Kordes; J Schneppenheim; Reinhard Schneppenheim
Related Documents :
2256469 - Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.
20110379 - Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.
16939069 - Nephrotic syndrome with focal segmental glomerulosclerosis after an insect bite.
12836099 - Stevens-johnson syndrome in a boy with nephrotic syndrome during prednisolone therapy.
6520839 - Felty's syndrome in a child.
7563279 - Filarial antibody detection in suspected occult filariasis in children in an endemic area.
22237929 - Posterior reversible encephalopathy syndrome: a case following reversible cerebral vaso...
17692189 - Metric analysis of the hard palate in children with down syndrome: a comparative study.
17987099 - Pulsed radiofrequency of the median nerve under ultrasound guidance.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hämostaseologie     Volume:  29     ISSN:  0720-9355     ISO Abbreviation:  Hamostaseologie     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-30     Completed Date:  2009-07-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8204531     Medline TA:  Hamostaseologie     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  155-7     Citation Subset:  IM    
Affiliation:
Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany. beutel@uke.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / therapeutic use
Child
Dexamethasone / therapeutic use
Factor IX / therapeutic use*
Hemophilia B / immunology*
Humans
Immune Tolerance*
Immunosuppressive Agents / therapeutic use*
Infant
Male
Mycophenolic Acid / analogs & derivatives*,  therapeutic use
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunosuppressive Agents; 0/rituximab; 128794-94-5/mycophenolate mofetil; 24280-93-1/Mycophenolic Acid; 50-02-2/Dexamethasone; 9001-28-9/Factor IX

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
Next Document:  The problem of novel FVIII missense mutations for haemophilia A genetic counseling.